14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days HK$32.30 HK$42.00 Thursday, 2nd May 2024 1801.HK stock ended at HK$41.85. This is 9.41% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 12.00% from a day low at HK$37.50 to a day high of HK$42.00.
90 days HK$28.30 HK$46.15
52 weeks HK$27.30 HK$49.80

Historical Innovent Biologics, Inc. prices

Date Open High Low Close Volume
May 02, 2024 HK$38.10 HK$42.00 HK$37.50 HK$41.85 7 914 927
Apr 30, 2024 HK$39.50 HK$40.40 HK$38.00 HK$38.25 8 629 492
Apr 29, 2024 HK$39.50 HK$40.50 HK$38.85 HK$39.75 8 879 787
Apr 26, 2024 HK$39.15 HK$39.95 HK$38.50 HK$39.15 7 286 643
Apr 25, 2024 HK$38.15 HK$39.70 HK$37.95 HK$38.55 7 877 936
Apr 24, 2024 HK$36.30 HK$38.50 HK$35.90 HK$38.15 9 468 453
Apr 23, 2024 HK$34.60 HK$36.65 HK$34.10 HK$36.15 8 682 141
Apr 22, 2024 HK$33.65 HK$34.75 HK$32.45 HK$33.95 6 874 289
Apr 19, 2024 HK$33.55 HK$33.55 HK$32.30 HK$33.20 5 694 087
Apr 18, 2024 HK$34.00 HK$34.45 HK$33.30 HK$33.70 8 517 389
Apr 17, 2024 HK$34.70 HK$35.00 HK$33.80 HK$34.30 6 394 614
Apr 16, 2024 HK$35.85 HK$36.35 HK$34.20 HK$34.70 5 838 579
Apr 15, 2024 HK$36.95 HK$37.25 HK$35.55 HK$35.85 5 788 923
Apr 12, 2024 HK$37.75 HK$38.25 HK$36.95 HK$37.35 3 804 624
Apr 11, 2024 HK$36.85 HK$37.65 HK$36.60 HK$37.40 5 970 402
Apr 10, 2024 HK$37.90 HK$38.20 HK$36.80 HK$37.50 5 468 693
Apr 09, 2024 HK$36.60 HK$38.20 HK$35.85 HK$38.05 6 922 562
Apr 08, 2024 HK$35.80 HK$37.30 HK$35.50 HK$36.55 5 116 792
Apr 05, 2024 HK$35.80 HK$36.20 HK$34.90 HK$35.75 1 548 650
Apr 03, 2024 HK$37.20 HK$37.35 HK$35.85 HK$36.15 6 456 354
Apr 02, 2024 HK$38.35 HK$38.90 HK$36.45 HK$37.70 6 894 983
Mar 28, 2024 HK$38.45 HK$38.75 HK$37.50 HK$37.70 7 021 800
Mar 27, 2024 HK$38.40 HK$39.10 HK$38.00 HK$38.45 5 589 408
Mar 26, 2024 HK$37.40 HK$38.95 HK$37.10 HK$38.55 7 182 908
Mar 25, 2024 HK$35.70 HK$38.30 HK$35.70 HK$37.30 10 764 021
Click to get the best stock tips daily for free!

About Innovent Biologics, Inc.

Innovent Biologics. Innovent Biologics, Inc. operates as a biopharmaceutical company in China. The company operates a platform for the discovery, development, and manufacture of antibody drug candidates in the fields of oncology, ophthalmology, immunology, and metabolic diseases. Its principal drug candidate is Tyvyt (sintilimab), an anti-PD-1 monoclonal antibody for the treatment of cancer, Hodgkin's lymphoma, and esophageal carcinoma. The company also offers Byvas... 1801.HK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT